Cara Therapeutics Inc (CARA): Market Value

Public company logo of Cara Therapeutics (CARA)

Cara Therapeutics, Inc. (CARA) focuses on developing treatments for neurological disorders and cutaneous hypersensitivity, having restructured its project portfolio in favor of early-stage development and cost optimization following the failure of Corsuvia. This price chart, serving as the primary valuation tool, correlates with the recruitment of top-tier chemists via stock options, while the market capitalization stands at 0.01. The absence of sales and the search for new growth trajectories have reduced the business's market value to a minimum.

Cara Therapeutics - CARA Market Capitalization (period 07/04/2022 - 11/17/2026)

CARA (Cara Therapeutics): analytical breakdowns and indicator data

Fundamental company analysis:CARA (Cara Therapeutics, Inc)
Product sample of caratherapeutics.com

Market capitalization represents the aggregate value of all outstanding shares, reflecting an objective market valuation of equity capital. For Cara Therapeutics, Inc. (CARA), this metric scales through the potential of unique molecules capable of driving global market expansion. Analyzing the issuer's total equity value allows investors to filter out speculative noise and assess real demand for the future profitability of its drugs. This chart helps identify points of overvaluation or undervaluation of the business, serving as the basis for buy or short decisions.

Key competitors

Market Capitalization BIIB (Biogen Idec)|Neurocrine Biosciences Inc - Market Value|regencellbioscience.com - Market Capitalization|Market Capitalization axsome.com AXSM|ACAD: Market Capitalization|Market Value Xenon Pharmaceuticals Inc. (XENE)|Market Value Viking Therapeutics|Market Capitalization SUPN (Supernus Pharma)|Market Capitalization CPRX|DNLI - Market Value|harmonybiosciences.com - Market Valuation|Market Capitalization Biohaven Ltd BHVN|AMLX - Market Value|Market Value TRVI (Trevi Corp)|Praxis Precision Medicines Inc (PRAX) - Market Value|Market Value Anavex Life Sciences (AVXL)|CBLL (CeriBell Inc) - Market Capitalization|Prothena Corporation - Market Valuation|Market Value Alector (ALEC)|Annexon Biosciences Inc. - Market Capitalization|Market Capitalization OMER (Omeros)|Market Capitalization neurogene.com NGNE|AC Immune S.A. - Market Capitalization|VYGR - Market Capitalization|neumoratx.com (NMRA) - Market Value|Market Value Scilex Holding Company (SCLX)|TVGN (Tevogen Bio Holdings Inc.) - Market Capitalization|ACOG: Market Value|Market Capitalization CGTX|Market Capitalization Inhibikase Therapeutics Inc (IKT)|Cassava - Market Valuation|assertiotx.com (ASRT) - Market Value|COYA - Market Value|Market Value VTGN (VistaGen Therapeutics, Inc.)|OVID: Market Capitalization|Acumen Pharmaceuticals Inc. (ABOS) - Market Capitalization|Market Value CervoMed Inc.|ATHE: Market Value|Market Value Clene (CLNN)|PEPG: Market Valuation|Market Value Jupiter Neurosciences, Inc. JUNS|Market Capitalization Relmada Therapeutics Inc RLMD|ANVS - Market Value|GRCE - Market Capitalization|AIFF: Market Capitalization|KLTO - Market Capitalization|NRSN (NeuroSense Therapeutics, Ltd.) - Market Capitalization|Market Capitalization Reviva Pharmaceuticals Holdings|Market Capitalization MTVA|Market Capitalization NeurAxis Inc|Helius Medical Technologies - Market Valuation|Market Capitalization Passage Bio, Inc. PASG|NEUP: Market Valuation|Minerva Neurosciences, Inc. (NERV) - Market Valuation|ATHA (Athira Pharma) - Market Valuation|Market Capitalization ADXN|Market Value Alzamend Neuro, Inc.|Market Valuation cyclerion.com (CYCN)|Market Capitalization PTIX|Market Capitalization Pasithea (KTTA)|Market Value Cortigent CRGT|Market Capitalization Avenue Therapeutics Inc (ATXI)|BCLI - Market Value|Chromocell Therapeutics (CHRO) - Market Valuation|ELYM (Eliem Therapeutics Inc.) - Market Valuation|ITCI - Market Capitalization|Market Value Longboard Pharma|Market Capitalization MRNS (Marinus Pharma)|Market Value NKGen Biotech Inc (NKGN)|NRBO - Market Value|Market Capitalization SAGE (Sage Therapeutics Inc)|Synaptogenix Inc. (SNPX) - Market Value|TRVN: Market Valuation|Market Capitalization vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Market Valuation|Market Valuation Cerevel Therapeutics